Profilo
Jason Chin is the founder of Constructive Bio Ltd.
He is currently working as an Independent Non-Executive Director at Genus Plc.
Posizioni attive di Jason Chin
Società | Posizione | Inizio |
---|---|---|
GENUS PLC | Director/Board Member | 01/04/2021 |
Constructive Bio Ltd.
Constructive Bio Ltd. BiotechnologyHealth Technology Constructive Bio Ltd. is a British biotechnology company that rewrites genomes to create biomolecules that were previously unimaginable. The company is based in Cambridge, UK and is backed by a world-class syndicate of investors including Ahren Innovation Capital, Amadeus Capital Partners, OMX Ventures, and General Inception. The company is creating next-generation therapeutics and industrial solutions while setting the standard for genetic code reprogramming. With a world-class team in synthetic genomics and a passionate commitment to improving health and bioprocessing, Constructive Bio is reimagining the world of biologic therapies by rewriting the genome itself. | Founder | - |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
GENUS PLC | Process Industries |
Aziende private | 1 |
---|---|
Constructive Bio Ltd.
Constructive Bio Ltd. BiotechnologyHealth Technology Constructive Bio Ltd. is a British biotechnology company that rewrites genomes to create biomolecules that were previously unimaginable. The company is based in Cambridge, UK and is backed by a world-class syndicate of investors including Ahren Innovation Capital, Amadeus Capital Partners, OMX Ventures, and General Inception. The company is creating next-generation therapeutics and industrial solutions while setting the standard for genetic code reprogramming. With a world-class team in synthetic genomics and a passionate commitment to improving health and bioprocessing, Constructive Bio is reimagining the world of biologic therapies by rewriting the genome itself. | Health Technology |
- Borsa valori
- Insiders
- Jason Chin